Docoh
Loading...

CRXM Taxus Cardium Pharmaceuticals

Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company. The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease; and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde on December 22, 2003 and is headquartered in San Diego, CA.

Company profile

Ticker
CRXM
Exchange
CEO
Christopher J. Reinhard
Employees
Incorporated
Location
Fiscal year end
Former names
Aries Ventures Inc, Cardium Therapeutics, Inc., Casmyn Corp, Taxus Cardium Pharmaceuticals Group Inc.
SEC CIK
IRS number
840635673

CRXM stock data

(
)

Calendar

4 Dec 18
13 Apr 21
31 Dec 21
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
17 Mar 21 Jemapete Christopher J Common Stock Buy Aquire P No No 0.402 200,000 80.4K 4,000,000
16 Mar 21 Jemapete Christopher J Common Stock Buy Aquire P No No 0.0399 300,000 11.97K 3,800,000

Financial report summary

?
Competition
Gilead Sciences
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: amenable, anniversary, asserted, bionomial, BLA, encompassing, GenerxTM, lattice, microstructural, Modernization, noncontrolling, shortly, situ, USPTO
Removed: accrue, annum, arising, assured, Berlex, Bulletin, canceled, case, CE, certification, collectability, customary, determinable, discontinued, dissolution, eliminating, formed, fourth, half, implemented, invested, iv, largest, lon, mandatorily, mark, maximum, met, move, mulroy, originally, park, performed, persuasive, piggyback, preference, receivable, refusal, Russia, SAB, supplement, title, trailing, tyler, unregistered, unused, utilized